The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Consumer >> CEO Interviews >> August 10, 2015

Interview with the CEO: DS Healthcare Group Inc. (DSKX)

Dan Khesin
Dan Khesin has served as Chief Executive Officer of DS Healthcare Group Inc. from its founding through its current success with annual sales of nearly $14 million, or over $60 million in sales since inception. He has established and maintained the company’s essential strategy: incorporating the latest high-performance biotechnology into the formulation and marketing of over-the-counter and pharmaceutical topical treatments for hair and skin. Prior to DS Healthcare, Mr. Khesin ran DK Design Group, a professional-audio company, where he managed investments, incubated new technologies and developed significant distribution, and ultimately sold the company. Before DK Design, he was Vice President of Operations at Free Razor, a continuity program for personal care products. Mr. Khesin attended Hunter College in New York City. Under the leadership of Mr. Khesin, DS Healthcare has had an annual increase of revenues for six consecutive years straight, indicating continued future growth. The company has also reached some major milestones including distribution into over 15 countries, including key markets such as Brazil and China. In July 2014, DS Laboratories announced it opened its first retail store in Shanghai, China. While Mr. Khesin has assembled the company’s core group of entrepreneurial managers, he has remained firmly engaged in capitalization, production, product development and marketing issues.     Profile
TWST: Please start with a brief introduction to DS Healthcare, and tell us what inspired you to start the company.

Mr. Khesin: I would say that DS Healthcare is most definitely one of

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy